Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis

被引:5
|
作者
Anderson, Kathryn L. [1 ]
Feldman, Steven R. [1 ,2 ,3 ]
机构
[1] Wake Forest Sch Med, Dept Dermatol, Ctr Dermatol Res, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC 27157 USA
[3] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
关键词
psoriasis; phototherapy; dermatology; TREATMENT PATTERNS; DRUG SURVIVAL; BIOLOGICS; DISCONTINUATION; POPULATION; ETANERCEPT; ADALIMUMAB; CARE; IMPAIRMENT; THERAPIES;
D O I
10.1177/1203475415572797
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Psoriasis treatment involves multiple treatment arms. Treatment choice depends on many factors and may change, due to the chronicity of psoriasis. Objective: The purpose of our study is to explore reasons for treatment changes in patients with moderate to severe psoriasis. Methods: Ten charts of patients with moderate to severe psoriasis were reviewed. The medication changes and reasons for change were extracted. A treatment change was defined as switching between medication classes, adding or removing a medication class, or switching medications within the oral or biologic medication class. Results: Seventy-seven treatment changes were identified. On average, I treatment change occurred per year of follow-up. The most common reason for treatment change was inadequate disease control. Conclusions: Inadequate disease control with current therapy is the most common reason a physician changes treatment for moderate to severe psoriasis. More efficacious treatments or ways to improve efficacy may help improve the long-term outcomes of psoriasis.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 50 条
  • [1] Treatment Changes in Patients With Moderate to Severe Psoriasis: A Retrospective Chart Review
    Smith, Jaclyn A.
    Wehausen, Brooke
    Richardson, Irma
    Zhao, Yang
    Li, Yunfeng
    Herrera, Vivian
    Feldman, Steven R.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2018, 22 (01) : 25 - 30
  • [2] Treatment Approaches to Moderate to Severe Psoriasis
    Gisondi, Paolo
    Del Giglio, Micol
    Girolomoni, Giampiero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [3] Advances in the treatment of moderate-to-severe plaque psoriasis
    Herrier, Richard N.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (09) : 795 - 806
  • [4] Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States
    Armstrong, April W.
    Koning, J. Will
    Rowse, Simon
    Tan, Huaming
    Mamolo, Carla
    Kaur, Mandeep
    CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 493 - 501
  • [5] Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis
    Yeung, Howa
    Wan, Joy
    Van Voorhees, Abby S.
    Duffin, Kristina Callis
    Krueger, Gerald G.
    Kalb, Robert E.
    Weisman, Jamie D.
    Sperber, Brian R.
    Brod, Bruce A.
    Schleicher, Stephen M.
    Bebo, Bruce F., Jr.
    Shin, Daniel B.
    Troxel, Andrea B.
    Gelfand, Joel M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (01) : 64 - 72
  • [6] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [7] The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    Gupta, Rishu
    Debbaneh, Maya
    Butler, Daniel
    Huynh, Monica
    Levin, Ethan
    Leon, Argentina
    Koo, John
    Liao, Wilson
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (77): : e50509
  • [8] Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan
    Tada, Yayoi
    Soliman, Ahmed M.
    Ishii, Kanako
    Sakuma, Ryuta
    Pinter, Andreas
    Davis, Matthew
    Nunag, Dominic
    Buessing, Marric
    Puig, Luis
    Imafuku, Shinichi
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (05)
  • [9] Biologic treatment sequences in moderate-to-severe psoriasis
    Ting, Samantha
    Lowe, Patricia
    Smith, Annika
    Fernandez-Penas, Pablo
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (07) : e178 - e186
  • [10] Tailored biological treatment for patients with moderate-to-severe psoriasis
    Maurelli, Martina
    Gisondi, Paolo
    Girolomoni, Giampiero
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 37 - 43